BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8560490)

  • 1. Isoflurane acts as an inhibitor of oxidative dehalogenation while acting as an accelerator of reductive dehalogenation of halothane in guinea pig liver microsomes.
    Fujii K
    Toxicology; 1995 Dec; 104(1-3):123-8. PubMed ID: 8560490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of corticoids on reductive halothane dehalogenation.
    Fujii K
    Drug Metabol Drug Interact; 1995; 12(1):37-43. PubMed ID: 7555000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerobic dehalogenation of halothane showing different substrate dependency from anaerobic dehalogenation in liver microsomes of guinea pig.
    Nakao M; Fujii K; Kinoshita H; Yuge O; Morio M
    Hiroshima J Med Sci; 1991 Mar; 40(1):23-8. PubMed ID: 1864763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
    Spracklin DK; Thummel KE; Kharasch ED
    Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of reductive dehalogenation of halothane by liver cytochrome P450.
    Ahr HJ; King LJ; Nastainczyk W; Ullrich V
    Biochem Pharmacol; 1982 Feb; 31(3):383-90. PubMed ID: 7073765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive effect of isoflurane on destruction of cytochrome P450 during reductive dehalogenation of carbon tetrachloride in guinea-pig liver microsomes.
    Fujii K
    Drug Metabol Drug Interact; 1997; 14(2):99-107. PubMed ID: 9893740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reductive halothane metabolite formation and halothane binding in rat hepatic microsomes.
    Baker MT; Van Dyke RA
    Chem Biol Interact; 1984 Apr; 49(1-2):121-32. PubMed ID: 6722932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulatory effect of anesthetics on dechlorination of carbon tetrachloride in guinea-pig liver microsomes.
    Fujii K
    Toxicology; 1996 Dec; 114(2):147-53. PubMed ID: 8947613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P4502A6 (CYP2A6).
    Minoda Y; Kharasch ED
    Anesthesiology; 2001 Aug; 95(2):509-14. PubMed ID: 11506127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductive metabolism of halothane by cytochrome P450 isoforms in rats and humans.
    Chow T; Imaoka S; Hiroi T; Funae Y
    Res Commun Mol Pathol Pharmacol; 1996 Sep; 93(3):363-74. PubMed ID: 8896047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoflurane increases the anaerobic metabolites of halothane.
    Rahman M; Fujii K; Sato N; Yuge O
    J Appl Toxicol; 1994; 14(1):43-6. PubMed ID: 8157869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human halothane metabolism, lipid peroxidation, and cytochromes P(450)2A6 and P(450)3A4.
    Kharasch ED; Hankins DC; Fenstamaker K; Cox K
    Eur J Clin Pharmacol; 2000; 55(11-12):853-9. PubMed ID: 10805064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of gomisi on reductive metabolism of halothane.
    Jiaxiang N; Fujii K; Sato N; Yuge O
    J Appl Toxicol; 1993; 13(6):385-8. PubMed ID: 8288841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the stability and cytochrome P450 specificity of the phenobarbital-induced reductive halothane-cytochrome P450 complex formed in rat hepatic microsomes.
    Baker MT; Vasquez MT; Chiang CK
    Biochem Pharmacol; 1991 Jun; 41(11):1691-9. PubMed ID: 2043158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro.
    Spracklin DK; Hankins DC; Fisher JM; Thummel KE; Kharasch ED
    J Pharmacol Exp Ther; 1997 Apr; 281(1):400-11. PubMed ID: 9103523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the reductive metabolism of halothane by microsomal cytochrome b5 in rat liver.
    Tamura S; Kawata S; Sugiyama T; Tarui S
    Biochim Biophys Acta; 1987 Dec; 926(3):231-8. PubMed ID: 3689822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulatory effects of halothane and isoflurane on fluoride release and cytochrome P-450 loss caused by metabolism of 2-chloro-1,1-difluoroethene, a halothane metabolite.
    Baker MT; Bates JN; Leff SV
    Anesth Analg; 1987 Nov; 66(11):1141-7. PubMed ID: 2889401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of paraquat on biotransformation of halothane in rabbit liver microsomes.
    Kawamoto M; Fujii K; Yuge O; Morio M
    Hiroshima J Med Sci; 1989 Dec; 38(4):161-7. PubMed ID: 2637243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of fluoroethane chlorofluorocarbon (CFC) substitutes with microsomal cytochrome P450. Stimulation of P450 activity and chlorodifluoroethene metabolism.
    Wang Y; Olson MJ; Baker MT
    Biochem Pharmacol; 1993 Jul; 46(1):87-94. PubMed ID: 8347140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
    Ferrara R; Tolando R; King LJ; Manno M
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.